# Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/why-do-pathological-stage-ia-lung-adenocarcinomas-vary-from-prognosis-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jie Zhang,Jie Wu,Qiang Tan,Lei Zhu,Wen Gao |
| Citations | 127 |
| DOI | 10.1097/jto.0b013e31829f09a7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086415334766/pdf |
| OpenAlex ID | https://openalex.org/W2068979002 |
| PMID | 23945388 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jie Zhang](https://scholariq.org/researchers/jie-zhang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.